{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:32:56Z","timestamp":1793010776980,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571223"],"award-info":[{"award-number":["82571223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388101"],"award-info":[{"award-number":["82388101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22475131"],"award-info":[{"award-number":["22475131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22375127"],"award-info":[{"award-number":["22375127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371102"],"award-info":[{"award-number":["82371102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52522307"],"award-info":[{"award-number":["52522307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401280"],"award-info":[{"award-number":["82401280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","award":["SHSMU-ZDCX20210700"],"award-info":[{"award-number":["SHSMU-ZDCX20210700"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23JC1402400"],"award-info":[{"award-number":["23JC1402400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.bioactmat.2026.08.040","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:37:24Z","timestamp":1790080644000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In situ bioactive nanocoating enables transocular delivery of permeable drug for dual-location intervention of ocular surface and fundus disorders"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6582-0972","authenticated-orcid":false,"given":"Zeqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengteng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2627-8701","authenticated-orcid":false,"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoran","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-9403","authenticated-orcid":false,"given":"Yan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-7060","authenticated-orcid":false,"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.08.040_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/343560","article-title":"Pathophysiology of diabetic retinopathy","volume":"2013","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.08.040_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(18)30128-1","article-title":"Incidence and progression of diabetic retinopathy: a systematic review","volume":"7","author":"Sabanayagam","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.08.040_bib3","first-page":"e888","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"Bourne","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.08.040_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/diabetology3010011","article-title":"Diabetic retinopathy: an overview on mechanisms, pathophysiology and pharmacotherapy","volume":"3","author":"Ansari","year":"2022","journal-title":"Diabetology"},{"key":"10.1016\/j.bioactmat.2026.08.040_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101039","article-title":"The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas","volume":"89","author":"Yu","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2026.08.040_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104599","article-title":"Deep learning for diabetic retinopathy detection and classification based on fundus images: a review","volume":"135","author":"Tsiknakis","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"23","key":"10.1016\/j.bioactmat.2026.08.040_bib9","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","volume":"378","author":"Clayton","year":"2018","journal-title":"Dry Eye. N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.08.040_bib10","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i10.109080","article-title":"Type 2 diabetes complicated by dry eye syndrome: analysis of dry eye symptoms, corneal neuropathy, and influencing factors","volume":"16","author":"Han","year":"2025","journal-title":"World J. Diabetes"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.08.040_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ajo.2009.12.005","article-title":"Topical mecamylamine for diabetic macular edema","volume":"149","author":"Campochiaro","year":"2010","journal-title":"Am. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.08.040_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","article-title":"Gelling hypotonic polymer solution for extended topical drug delivery to the eye","volume":"4","author":"Kim","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/17425247.2019.1553953","article-title":"Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases","volume":"16","author":"Shatz","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-60761-938-3_5","article-title":"The blood-retinal barrier: structure and functional significance","volume":"686","author":"Runkle","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.08.040_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","article-title":"Applications of nanoparticles in ophthalmology","volume":"29","author":"Diebold","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.08.040_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419263","article-title":"The optimized lipid\u2010modified prodrug for CNV treatment","volume":"37","author":"Lv","year":"2025","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.bioactmat.2026.08.040_bib17","doi-asserted-by":"crossref","first-page":"25377","DOI":"10.1021\/acsnano.3c08869","article-title":"Multifunctional hydrogel eye drops for synergistic treatment of ocular inflammatory disease","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.08.040_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/1061186X.2017.1280809","article-title":"Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy","volume":"25","author":"Selvaraj","year":"2017","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.08.040_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/gels10030193","article-title":"Thermosensitive in situ gelling poloxamers\/hyaluronic acid gels for hydrocortisone ocular delivery","volume":"10","author":"Villapiano","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.bioactmat.2026.08.040_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.174711","article-title":"Celastrol-loaded micelles with dual-mucoadhesive strategy for efficient suppression of corneal neovascularization","volume":"534","author":"Zhu","year":"2026","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12951-025-03727-x","article-title":"Amorphous layered double hydroxide-based nano-enzyme eye drops against dry eye disease by inhibiting mitochondrial damage and pyroptosis","volume":"23","author":"Chu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202403935","article-title":"Membrane fusion-mediated loading of therapeutic siRNA into exosome for tissue-specific application","volume":"36","author":"Xie","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib23","article-title":"Cationic liposome-mediated scavenging of cell-free DNA: an innovative and alternative therapeutic approach for efficient treatment of dry eye disease","volume":"522","author":"Wang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib24","article-title":"Cornea-SELEX for aptamers targeting the surface of eyes and liposomal drug delivery","volume":"4","author":"Wong","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.bioactmat.2026.08.040_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pharmaceutics14010134","article-title":"Topical drug delivery to the posterior segment of the eye","volume":"14","author":"L\u00f6scher","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib27","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1038\/s41467-025-63553-5","article-title":"Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanosterol synthase ameliorates cataract in rats","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111277","article-title":"Functionalized hydrogels in ophthalmic applications: ocular inflammation, corneal injuries, vitreous substitutes and intravitreal injection","volume":"224","author":"Gong","year":"2022","journal-title":"Mater. Des."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.08.040_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/vop.13264","article-title":"Low\u2010dose intravitreal injection of 4 mg preservative\u2010free gentamicin and superficial lamellar keratectomy combined with modified Gundersen grafts to control chronic heterochromic iridocyclitis and secondary keratitis in horses","volume":"28","author":"Charnock","year":"2024","journal-title":"Vet. Ophthalmol."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.08.040_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.08.040_bib31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/MS9.0000000000000345","article-title":"Dropped nucleus postintravitreal injection with intact anterior capsule: a case report","volume":"85","author":"Al-Latayfeh","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.08.040_bib32","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00417-021-05071-w","article-title":"Effectiveness of immediate vitrectomy and intravitreal antibiotics for post-injection endophthalmitis","volume":"259","author":"Januschowski","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.08.040_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2024.10.015","article-title":"Intravitreal Melphalan for vitreous metastases from cutaneous Melanoma","volume":"132","author":"Cain","year":"2025","journal-title":"Ophthalmology."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121361","article-title":"Glycopeptide-nanotransforrs eyedrops with enhanced permeability and retention for preventing fundus neovascularization","volume":"281","author":"Li","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.08.040_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.138291","article-title":"Neovascularization-directed bionic eye drops for noninvasive renovation of age-related macular degeneration","volume":"450","author":"Ran","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112212","article-title":"Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases","volume":"127","author":"Fang","year":"2021","journal-title":"Mater. Sci. Eng."},{"issue":"30","key":"10.1016\/j.bioactmat.2026.08.040_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt8775","article-title":"Thermoresponsive antioxidant metal-free carbon nanodot hydrogel: an effective therapeutic approach for ocular surface disease","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120900","article-title":"An antibody-like peptidic network for anti-angiogenesis","volume":"275","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioactmat.2026.08.040_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.bioactmat.2026.08.040_bib40","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12951-024-02503-7","article-title":"Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage","volume":"22","author":"Xia","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.08.040_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4103\/1673-5374.322457","article-title":"Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies","volume":"17","author":"Oshitari","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.08.040_bib43","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1039\/D0RA00343C","article-title":"Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach","volume":"11","author":"Ge","year":"2021","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.08.040_bib44","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/jnc.16190","article-title":"Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants","volume":"168","author":"Kumar","year":"2024","journal-title":"J. Neurochem."},{"issue":"7684","key":"10.1016\/j.bioactmat.2026.08.040_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature25013","article-title":"Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy","volume":"552","author":"Hu","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/acschembio.7b00854","article-title":"Chemical proteomics reveals soluble epoxide hydrolase as a therapeutic target for ocular neovascularization","volume":"13","author":"Sulaiman","year":"2017","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/acs.jmedchem.0c01507","article-title":"Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products","volume":"64","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.08.040_bib48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1476-5381.2008.00009.x","article-title":"Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation","volume":"156","author":"Liu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.prostaglandins.2016.08.004","article-title":"Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels","volume":"132","author":"Katary","year":"2017","journal-title":"Prostaglandins Other Lipid Mediators"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib50","first-page":"44","article-title":"Progress of research on sustained-release and long-acting ophthalmic preparations","volume":"49","author":"Yin","year":"2025","journal-title":"Prog. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsb.2009.03.012","article-title":"Determining the mechanical properties of human corneal basement membranes with atomic force microscopy","volume":"167","author":"Last","year":"2009","journal-title":"J. Struct. Biol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-022-01458-z","article-title":"MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes","volume":"21","author":"Veitch","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib53","article-title":"Synergy of phospholipid and hyaluronan based super-lubricated hydrogels","volume":"27","author":"Feng","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.08.040_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl6449","article-title":"Injectable hydrogel microspheres with self-renewable hydration layers alleviate osteoarthritis","volume":"8","author":"Lei","year":"2022","journal-title":"Sci. Adv."},{"issue":"6514","key":"10.1016\/j.bioactmat.2026.08.040_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.aay8276","article-title":"Cartilage-inspired, lipid-based boundary-lubricated hydrogels","volume":"370","author":"Lin","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib56","article-title":"Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond","volume":"7","author":"Bu","year":"2019","journal-title":"BMJ Open Diab. Res. Ca."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.preteyeres.2013.07.002","article-title":"Regional morphology and pathophysiology of retinal vascular disease","volume":"36","author":"Bek","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.08.040_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cxo.12318","article-title":"Retinal tissue thickness in type 1 and type 2 diabetes","volume":"99","author":"Srinivasan","year":"2021","journal-title":"Clin. Exp. Optom."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.08.040_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/opo.12263","article-title":"Retinal thickness profile of individuals with diabetes","volume":"36","author":"Srinivasan","year":"2015","journal-title":"Ophthal. Physl. Opt."},{"key":"10.1016\/j.bioactmat.2026.08.040_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6838976","article-title":"A review on recent developments for detection of diabetic retinopathy","volume":"2016","author":"Amin","year":"2016","journal-title":"Scientifica"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.08.040_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106688","article-title":"Trigeminal nerve-derived substance P regulates limbal stem cells by the PI3K-AKT pathway","volume":"26","author":"Xu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bioactmat.2026.08.040_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106660","article-title":"Fu-Huang ointment ameliorates impaired wound healing associated with diabetes through PI3K-AKT signalling pathway activation","volume":"155","author":"Qu","year":"2023","journal-title":"Comput. Biol. Med."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26005037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26005037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T09:38:03Z","timestamp":1793007483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26005037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":62,"alternative-id":["S2452199X26005037"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.08.040","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ bioactive nanocoating enables transocular delivery of permeable drug for dual-location intervention of ocular surface and fundus disorders","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}